HAEMONETICS CORP - Common Stock (HAE)

Historical Holders from Q1 2014 to Q3 2025

Symbol
HAE on NYSE
CUSIP
405024100
Type / Class
Equity / Common Stock
Shares outstanding
47.9M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
51.3M
Holdings value
$2.5B
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
291
Number of buys
147
Number of sells
-168
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of HAEMONETICS CORP - Common Stock (HAE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLINGTON MANAGEMENT GROUP LLP 4.6% -16% $138M -$30.3M 2.2M -18% Wellington Management Group LLP Jun 30, 2025
T. Rowe Price Investment Management, Inc. 4.4% $130M 2.2M T. Rowe Price Investment Management, Inc. Mar 31, 2025
Capital Research Global Investors 3.1% $93.5M 1.58M Capital Research Global Investors Mar 31, 2025

Institutional Holders of HAEMONETICS CORP - Common Stock (HAE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 51.3M $2.5B -$235M $48.74 291
2025 Q2 54.2M $4.05B +$50.2M $74.61 296
2025 Q1 53.7M $3.41B -$213M $63.55 312
2024 Q4 56.6M $4.42B +$78.5M $78.08 304
2024 Q3 55.4M $4.45B -$61.8M $80.38 303
2024 Q2 55.8M $4.62B +$425M $82.73 314
2024 Q1 50.7M $4.33B +$21.2M $85.35 295
2023 Q4 3.61M $309M -$2.97M $85.51 3
2023 Q3 50M $4.48B +$16.7M $89.58 292
2023 Q2 49.8M $4.24B -$31M $85.14 286
2023 Q1 49.8M $4.12B +$10.7M $82.75 293
2022 Q4 50.4M $3.96B -$106M $78.65 285
2022 Q3 51.2M $3.79B -$11M $74.03 254
2022 Q2 51.8M $3.37B +$47.6M $65.18 226
2022 Q1 51.2M $3.24B +$122M $63.22 222
2021 Q4 50.1M $2.65B -$89M $53.04 238
2021 Q3 50.7M $3.58B -$462K $70.59 243
2021 Q2 50.7M $3.38B -$105M $66.64 253
2021 Q1 46.7M $5.19B -$31.3M $111.01 284
2020 Q4 46.5M $5.53B +$22.2M $118.75 270
2020 Q3 46.4M $4.05B +$9.98M $87.25 256
2020 Q2 49.4M $4.42B -$131M $89.56 273
2020 Q1 50.5M $5.03B +$58.4M $99.66 260
2019 Q4 49.8M $5.73B -$8.43M $114.90 290
2019 Q3 49.6M $6.26B -$157M $126.14 271
2019 Q2 50.9M $6.12B +$155M $120.34 252
2019 Q1 51.3M $4.49B +$59M $87.48 253
2018 Q4 50.4M $5.05B -$150M $100.05 276
2018 Q3 51.7M $5.92B +$211M $114.58 289
2018 Q2 50.4M $4.52B -$96M $89.68 285
2018 Q1 52.5M $3.84B +$18.9M $73.16 253
2017 Q4 53.6M $3.11B -$26.1M $58.08 237
2017 Q3 54.7M $2.46B -$29.4M $44.87 201
2017 Q2 54.8M $2.16B +$24.9M $39.49 189
2017 Q1 54.6M $2.22B +$337M $40.57 174
2016 Q4 52.5M $2.11B +$26.3M $40.20 190
2016 Q3 51.1M $1.85B +$9.56M $36.21 171
2016 Q2 48.2M $1.4B -$27M $28.99 167
2016 Q1 51.2M $1.79B +$9.49M $34.98 157
2015 Q4 51.1M $1.65B -$35.2M $32.24 156
2015 Q3 52.1M $1.68B -$45.3M $32.32 167
2015 Q2 52.8M $2.19B -$10.6M $41.36 174
2015 Q1 53.8M $2.41B -$14.8M $44.92 167
2014 Q4 54.2M $2.03B +$23.1M $37.42 170
2014 Q3 52.1M $1.82B -$47.8M $34.92 166
2014 Q2 54.5M $1.92B +$20.4M $35.28 172
2014 Q1 54.2M $1.77B -$103M $32.59 187